Mixed Hormone Receptor (ER+/PR- Or ER-/PR+) Breast Cancer

Detailed information on mixed hormone receptor (ER+/PR- or ER-/PR+) breast cancer prognosis, based on the latest scientific studies.

Frontiers Prognostic Relevance of Estrogen Receptor Status in Circulating Tumor Cells in Breast Cancer Patients Treated With Endocrine Therapy

Challenges in Treating Estrogen Receptor-Positive Breast Cancer

IJMS, Free Full-Text

Endocrine and Cell Surface Receptor Signaling in Breast Carcinogenesis

Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer

Frontiers Single Hormone Receptor-Positive Metaplastic Breast Cancer: Similar Outcome as Triple-Negative Subtype

Frontiers Characteristics and survival in bone metastatic breast cancer patients with different hormone receptor status: A population-based cohort study

Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer

Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor

Cancers, Free Full-Text